SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-159435
Filing Date
2023-06-02
Accepted
2023-06-02 08:15:59
Documents
19
Period of Report
2023-05-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d484383d8k.htm   iXBRL 8-K 41467
2 EX-10.1 d484383dex101.htm EX-10.1 175675
3 EX-99.1 d484383dex991.htm EX-99.1 11571
7 GRAPHIC g484383g13a01.jpg GRAPHIC 13267
8 GRAPHIC g484383g13a02.jpg GRAPHIC 13378
9 GRAPHIC g484383g30a01.jpg GRAPHIC 10223
10 GRAPHIC g484383g39w39.jpg GRAPHIC 10433
11 GRAPHIC g484383g54m41.jpg GRAPHIC 3193
  Complete submission text file 0001193125-23-159435.txt   466872

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA meip-20230531.xsd EX-101.SCH 2855
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE meip-20230531_lab.xml EX-101.LAB 17993
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE meip-20230531_pre.xml EX-101.PRE 11264
13 EXTRACTED XBRL INSTANCE DOCUMENT d484383d8k_htm.xml XML 3342
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-50484 | Film No.: 23986806
SIC: 2834 Pharmaceutical Preparations